Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: A randomized double-masked clinical trial

European Journal of Ophthalmology

Volumn 18, Issue 2, 2008, Pages 263-269

  Mirshahi, A ^a   Roohipoor, R ^a   Lashay, A ^a   Mohammadi, Seyed Farzad ^a   Abdoallahi, A ^a   Faghihi, H ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti VEGF bevacizumab; Hemoglobin A1c; Proliferative diabetic retinopathy; Retinal laser photocoagulation

Indexed keywords

BEVACIZUMAB; HEMOGLOBIN A1C;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIOLOGICAL THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOUBLE BLIND PROCEDURE; ENDOPHTHALMITIS; FEMALE; FLUORESCENCE ANGIOGRAPHY; HIGH RISK PATIENT; HUMAN; INTRAOCULAR HEMORRHAGE; INTRAOCULAR PRESSURE; LASER COAGULATION; LENS; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REMISSION; SIDE EFFECT; TREATMENT OUTCOME; UVEITIS;

EID: 43749087641     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210801800215     Document Type: Article

References (31)